Wernicke's encephalopathy : An excitotoxicity hypothesis
Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms tha...
Gespeichert in:
Veröffentlicht in: | Metabolic brain disease 1997-09, Vol.12 (3), p.183-192 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 192 |
---|---|
container_issue | 3 |
container_start_page | 183 |
container_title | Metabolic brain disease |
container_volume | 12 |
creator | MCENTEE, W. J |
description | Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms that determine the formation and distribution of brain lesions identified with this illness are not understood. It is proposed here that glutamate neurotoxicity causes the brain lesions in WE. Glutamic acid decarboxylase (GAD), an enzyme mainly confined to the central nervous system, protects most regions of the brain from glutamate that accumulates when the activity of alpha-ketoglutarate dehydrogenase, a thiamine-dependent enzyme complex, is reduced. During severe thiamine deficiency, glutamate accumulates in GAD-free peripheral tissues and reaches a concentration in blood at which it passes through circumventricular organs into the cerebral ventricles or contiguous brain and finally diffuses into the extracellular space of proximate diencephalic and brain stem tissues. Extracellular glutamate eventually reaches neurotoxic levels in those tissues and causes the characteristic lesions of WE. |
doi_str_mv | 10.1007/BF02674611 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16432938</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>532723061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-5f2da04449f412eb0306990fa54ce31ccab9b99affd2420d35d3dfafca1f73d13</originalsourceid><addsrcrecordid>eNpd0M1LwzAYBvAgypzTi3ehiCgI1TcfTRpvczgVBl4UjyVNE9rZNbVpYf3vraxM8PQenh8PLw9C5xjuMIC4f1wC4YJxjA_QFEeChoLy6BBNIY6jUDAJx-jE-zUA0AjLCZpIyjjjYoriT9NUhf4yNz4wlTZ1rkpXqzbvg4dgXgVmq4vWtW5bDLcP8r52bW584U_RkVWlN2fjnaGP5dP74iVcvT2_LuarUFPAbRhZkilgjEnLMDEpUOBSglUR04ZirVUqUymVtRlhBDIaZTSzymqFraAZpjN0veutG_fdGd8mm8JrU5aqMq7zCeaMEknjAV7-g2vXNdXwW0IIxhIiygd0u0O6cd43xiZ1U2xU0ycYkt8tk78tB3wxNnbpxmR7Oo435FdjrrxWpW1UpQu_ZyRmPBZAfwDzHHo6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>221190536</pqid></control><display><type>article</type><title>Wernicke's encephalopathy : An excitotoxicity hypothesis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>MCENTEE, W. J</creator><creatorcontrib>MCENTEE, W. J</creatorcontrib><description>Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms that determine the formation and distribution of brain lesions identified with this illness are not understood. It is proposed here that glutamate neurotoxicity causes the brain lesions in WE. Glutamic acid decarboxylase (GAD), an enzyme mainly confined to the central nervous system, protects most regions of the brain from glutamate that accumulates when the activity of alpha-ketoglutarate dehydrogenase, a thiamine-dependent enzyme complex, is reduced. During severe thiamine deficiency, glutamate accumulates in GAD-free peripheral tissues and reaches a concentration in blood at which it passes through circumventricular organs into the cerebral ventricles or contiguous brain and finally diffuses into the extracellular space of proximate diencephalic and brain stem tissues. Extracellular glutamate eventually reaches neurotoxic levels in those tissues and causes the characteristic lesions of WE.</description><identifier>ISSN: 0885-7490</identifier><identifier>EISSN: 1573-7365</identifier><identifier>DOI: 10.1007/BF02674611</identifier><identifier>PMID: 9346467</identifier><identifier>CODEN: MBDIEE</identifier><language>eng</language><publisher>New York, NY: Springer</publisher><subject>Animals ; Biological and medical sciences ; Brain - metabolism ; Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes ; gamma-Aminobutyric Acid - metabolism ; Glutamic Acid - physiology ; Humans ; Medical sciences ; Models, Neurological ; Nervous system (semeiology, syndromes) ; Neurology ; Neurotoxins - metabolism ; Thiamine Deficiency - complications ; Wernicke Encephalopathy - etiology</subject><ispartof>Metabolic brain disease, 1997-09, Vol.12 (3), p.183-192</ispartof><rights>1997 INIST-CNRS</rights><rights>Copyright Kluwer Academic Publishers Sep 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c301t-5f2da04449f412eb0306990fa54ce31ccab9b99affd2420d35d3dfafca1f73d13</citedby><cites>FETCH-LOGICAL-c301t-5f2da04449f412eb0306990fa54ce31ccab9b99affd2420d35d3dfafca1f73d13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27926,27927</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2846870$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9346467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MCENTEE, W. J</creatorcontrib><title>Wernicke's encephalopathy : An excitotoxicity hypothesis</title><title>Metabolic brain disease</title><addtitle>Metab Brain Dis</addtitle><description>Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms that determine the formation and distribution of brain lesions identified with this illness are not understood. It is proposed here that glutamate neurotoxicity causes the brain lesions in WE. Glutamic acid decarboxylase (GAD), an enzyme mainly confined to the central nervous system, protects most regions of the brain from glutamate that accumulates when the activity of alpha-ketoglutarate dehydrogenase, a thiamine-dependent enzyme complex, is reduced. During severe thiamine deficiency, glutamate accumulates in GAD-free peripheral tissues and reaches a concentration in blood at which it passes through circumventricular organs into the cerebral ventricles or contiguous brain and finally diffuses into the extracellular space of proximate diencephalic and brain stem tissues. Extracellular glutamate eventually reaches neurotoxic levels in those tissues and causes the characteristic lesions of WE.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Brain - metabolism</subject><subject>Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes</subject><subject>gamma-Aminobutyric Acid - metabolism</subject><subject>Glutamic Acid - physiology</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Models, Neurological</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neurotoxins - metabolism</subject><subject>Thiamine Deficiency - complications</subject><subject>Wernicke Encephalopathy - etiology</subject><issn>0885-7490</issn><issn>1573-7365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNpd0M1LwzAYBvAgypzTi3ehiCgI1TcfTRpvczgVBl4UjyVNE9rZNbVpYf3vraxM8PQenh8PLw9C5xjuMIC4f1wC4YJxjA_QFEeChoLy6BBNIY6jUDAJx-jE-zUA0AjLCZpIyjjjYoriT9NUhf4yNz4wlTZ1rkpXqzbvg4dgXgVmq4vWtW5bDLcP8r52bW584U_RkVWlN2fjnaGP5dP74iVcvT2_LuarUFPAbRhZkilgjEnLMDEpUOBSglUR04ZirVUqUymVtRlhBDIaZTSzymqFraAZpjN0veutG_fdGd8mm8JrU5aqMq7zCeaMEknjAV7-g2vXNdXwW0IIxhIiygd0u0O6cd43xiZ1U2xU0ycYkt8tk78tB3wxNnbpxmR7Oo435FdjrrxWpW1UpQu_ZyRmPBZAfwDzHHo6</recordid><startdate>19970901</startdate><enddate>19970901</enddate><creator>MCENTEE, W. J</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>19970901</creationdate><title>Wernicke's encephalopathy : An excitotoxicity hypothesis</title><author>MCENTEE, W. J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-5f2da04449f412eb0306990fa54ce31ccab9b99affd2420d35d3dfafca1f73d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Brain - metabolism</topic><topic>Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes</topic><topic>gamma-Aminobutyric Acid - metabolism</topic><topic>Glutamic Acid - physiology</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Models, Neurological</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neurotoxins - metabolism</topic><topic>Thiamine Deficiency - complications</topic><topic>Wernicke Encephalopathy - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MCENTEE, W. J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Psychology Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Metabolic brain disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MCENTEE, W. J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Wernicke's encephalopathy : An excitotoxicity hypothesis</atitle><jtitle>Metabolic brain disease</jtitle><addtitle>Metab Brain Dis</addtitle><date>1997-09-01</date><risdate>1997</risdate><volume>12</volume><issue>3</issue><spage>183</spage><epage>192</epage><pages>183-192</pages><issn>0885-7490</issn><eissn>1573-7365</eissn><coden>MBDIEE</coden><abstract>Thiamine deficiency is a recognized cause of Wernicke's encephalopathy (WE), a condition in which small necrotic lesions are found in close proximity to the third and fourth ventricles and the Sylvian aqueduct. Although the neuropathology of WE is well-established, the pathogenic mechanisms that determine the formation and distribution of brain lesions identified with this illness are not understood. It is proposed here that glutamate neurotoxicity causes the brain lesions in WE. Glutamic acid decarboxylase (GAD), an enzyme mainly confined to the central nervous system, protects most regions of the brain from glutamate that accumulates when the activity of alpha-ketoglutarate dehydrogenase, a thiamine-dependent enzyme complex, is reduced. During severe thiamine deficiency, glutamate accumulates in GAD-free peripheral tissues and reaches a concentration in blood at which it passes through circumventricular organs into the cerebral ventricles or contiguous brain and finally diffuses into the extracellular space of proximate diencephalic and brain stem tissues. Extracellular glutamate eventually reaches neurotoxic levels in those tissues and causes the characteristic lesions of WE.</abstract><cop>New York, NY</cop><pub>Springer</pub><pmid>9346467</pmid><doi>10.1007/BF02674611</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-7490 |
ispartof | Metabolic brain disease, 1997-09, Vol.12 (3), p.183-192 |
issn | 0885-7490 1573-7365 |
language | eng |
recordid | cdi_proquest_miscellaneous_16432938 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Biological and medical sciences Brain - metabolism Disorders of higher nervous function. Focal brain diseases. Central vestibular syndrome and deafness. Brain stem syndromes gamma-Aminobutyric Acid - metabolism Glutamic Acid - physiology Humans Medical sciences Models, Neurological Nervous system (semeiology, syndromes) Neurology Neurotoxins - metabolism Thiamine Deficiency - complications Wernicke Encephalopathy - etiology |
title | Wernicke's encephalopathy : An excitotoxicity hypothesis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T19%3A12%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Wernicke's%20encephalopathy%20:%20An%20excitotoxicity%20hypothesis&rft.jtitle=Metabolic%20brain%20disease&rft.au=MCENTEE,%20W.%20J&rft.date=1997-09-01&rft.volume=12&rft.issue=3&rft.spage=183&rft.epage=192&rft.pages=183-192&rft.issn=0885-7490&rft.eissn=1573-7365&rft.coden=MBDIEE&rft_id=info:doi/10.1007/BF02674611&rft_dat=%3Cproquest_cross%3E532723061%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=221190536&rft_id=info:pmid/9346467&rfr_iscdi=true |